Gyan Chandra

Array ( [id] => 7511548 [patent_doc_number] => 20110257258 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'Method for Preventing and Treating Avian Influenza in Human' [patent_app_type] => utility [patent_app_number] => 13/167544 [patent_app_country] => US [patent_app_date] => 2011-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3315 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20110257258.pdf [firstpage_image] =>[orig_patent_app_number] => 13167544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5938112 [patent_doc_number] => 20110213164 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'NOVEL COMPOUND CERAMIDASTIN, METHOD FOR PRODUCING THE SAME, AND USE OF THE SAME' [patent_app_type] => utility [patent_app_number] => 13/037684 [patent_app_country] => US [patent_app_date] => 2011-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5804 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20110213164.pdf [firstpage_image] =>[orig_patent_app_number] => 13037684 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4583700 [patent_doc_number] => 07851443 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-14 [patent_title] => 'Combination comprising combretastatin and anticancer agents' [patent_app_type] => utility [patent_app_number] => 12/142130 [patent_app_country] => US [patent_app_date] => 2008-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3459 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/851/07851443.pdf [firstpage_image] =>[orig_patent_app_number] => 12142130 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5508458 [patent_doc_number] => 20090081665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'METHOD OF DIAGNOSIS/PROGNOSIS OF HUMAN CHRONIC LYMPHOCYTIC LEUKEMIA COMPRISING THE PROFILING OF LPL/ADAM GENES' [patent_app_type] => utility [patent_app_number] => 12/109246 [patent_app_country] => US [patent_app_date] => 2008-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13964 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20090081665.pdf [firstpage_image] =>[orig_patent_app_number] => 12109246 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5285518 [patent_doc_number] => 20090099193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'EML4-ALK FUSION GENE' [patent_app_type] => utility [patent_app_number] => 12/100595 [patent_app_country] => US [patent_app_date] => 2008-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10074 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20090099193.pdf [firstpage_image] =>[orig_patent_app_number] => 12100595 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 239279 [patent_doc_number] => 07591994 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-22 [patent_title] => 'Camptothecin-binding moiety conjugates' [patent_app_type] => utility [patent_app_number] => 12/026811 [patent_app_country] => US [patent_app_date] => 2008-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 20511 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/591/07591994.pdf [firstpage_image] =>[orig_patent_app_number] => 12026811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5527721 [patent_doc_number] => 20090197798 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-06 [patent_title] => 'COMPOSITION FOR TREATING CANCER AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/026537 [patent_app_country] => US [patent_app_date] => 2008-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 5796 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20090197798.pdf [firstpage_image] =>[orig_patent_app_number] => 12026537 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 132796 [patent_doc_number] => 07696159 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-13 [patent_title] => 'Treatment for basal cell carcinoma' [patent_app_type] => utility [patent_app_number] => 12/008961 [patent_app_country] => US [patent_app_date] => 2008-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4862 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/696/07696159.pdf [firstpage_image] =>[orig_patent_app_number] => 12008961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 81270 [patent_doc_number] => 07745173 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-29 [patent_title] => 'Histone deacetylase and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/013277 [patent_app_country] => US [patent_app_date] => 2008-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 27663 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/745/07745173.pdf [firstpage_image] =>[orig_patent_app_number] => 12013277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4746150 [patent_doc_number] => 20080090752 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-17 [patent_title] => 'Anti-tumor vasculature effects of human serum albumin derivatives' [patent_app_type] => utility [patent_app_number] => 11/987855 [patent_app_country] => US [patent_app_date] => 2007-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4358 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20080090752.pdf [firstpage_image] =>[orig_patent_app_number] => 11987855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4727976 [patent_doc_number] => 20080207520 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Tumor-associated Peptides Binding Promiscuously to Human Leukocyte Antigen (HLA) Class II Molecules' [patent_app_type] => utility [patent_app_number] => 11/942573 [patent_app_country] => US [patent_app_date] => 2007-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 23184 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207520.pdf [firstpage_image] =>[orig_patent_app_number] => 11942573 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4576894 [patent_doc_number] => 07833739 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-16 [patent_title] => 'CA IX-specific inhibitors' [patent_app_type] => utility [patent_app_number] => 11/929816 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 24 [patent_no_of_words] => 28536 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 267 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/833/07833739.pdf [firstpage_image] =>[orig_patent_app_number] => 11929816 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4751882 [patent_doc_number] => 20080159955 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'CA IX-Specific Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/929601 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 28425 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20080159955.pdf [firstpage_image] =>[orig_patent_app_number] => 11929601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4576875 [patent_doc_number] => 07833738 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-16 [patent_title] => 'CA IX-specific inhibitors' [patent_app_type] => utility [patent_app_number] => 11/929774 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 24 [patent_no_of_words] => 28537 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 239 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/833/07833738.pdf [firstpage_image] =>[orig_patent_app_number] => 11929774 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4576863 [patent_doc_number] => 07833737 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-16 [patent_title] => 'CA IX-specific inhibitors' [patent_app_type] => utility [patent_app_number] => 11/929536 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 22 [patent_no_of_words] => 28481 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/833/07833737.pdf [firstpage_image] =>[orig_patent_app_number] => 11929536 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4567581 [patent_doc_number] => 07829065 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-09 [patent_title] => 'CA IX-specific inhibitors' [patent_app_type] => utility [patent_app_number] => 11/924587 [patent_app_country] => US [patent_app_date] => 2007-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 16 [patent_no_of_words] => 23299 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 199 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/829/07829065.pdf [firstpage_image] =>[orig_patent_app_number] => 11924587 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4812806 [patent_doc_number] => 20080193437 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'IMMUNOSTIMULATORY OLIGONUCLEOTIDE MULTIMERS' [patent_app_type] => utility [patent_app_number] => 11/876913 [patent_app_country] => US [patent_app_date] => 2007-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 25143 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20080193437.pdf [firstpage_image] =>[orig_patent_app_number] => 11876913 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4710597 [patent_doc_number] => 20080299123 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-04 [patent_title] => 'TREATMENT OF CHEMOTHERAPY- OR RADIOTHERAPY-RESISTANT TUMORS' [patent_app_type] => utility [patent_app_number] => 11/868278 [patent_app_country] => US [patent_app_date] => 2007-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 29343 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20080299123.pdf [firstpage_image] =>[orig_patent_app_number] => 11868278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5290413 [patent_doc_number] => 20090023143 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'Predicting agent for metastasis' [patent_app_type] => utility [patent_app_number] => 11/905296 [patent_app_country] => US [patent_app_date] => 2007-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18882 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20090023143.pdf [firstpage_image] =>[orig_patent_app_number] => 11905296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4727962 [patent_doc_number] => 20080207506 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Nucleotide and Protein Sequence of Mammastatin and Methods of Use' [patent_app_type] => utility [patent_app_number] => 11/838654 [patent_app_country] => US [patent_app_date] => 2007-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 15243 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207506.pdf [firstpage_image] =>[orig_patent_app_number] => 11838654 [rel_patent_id] =>[rel_patent_doc_number] =>)